[Federal Register Volume 75, Number 78 (Friday, April 23, 2010)]
[Notices]
[Page 21300]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-9420]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0159]


North American Bioproducts Corp.; Filing of Food Additive 
Petition (Animal Use); Erythromycin Thiocyanate

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that 
North American Bioproducts Corp. has filed a petition proposing that 
the food additive regulations be amended to provide for the safe use of 
erythromycin thiocyanate as an antimicrobial processing aid in fuel-
ethanol fermentations with respect to its consequent presence in by-
product distiller grains used as an animal feed or feed ingredient.

DATES: Submit written or electronic comments on the petitioner's 
environmental assessment May 24, 2010.

ADDRESSES:  You may submit written comments to the Division of Dockets 
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, 
rm. 1061, Rockville, MD 20852. Submit electronic comments to http://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Isabel W. Pocurull, Center for 
Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., 
Rockville, MD 20855, 240-453-6853, email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic 
Act (section 409(b)(5) (21 U.S.C. 348(b)(5)), notice is given that a 
food additive petition (FAP 2263) has been filed by North American 
Bioproducts Corp., Corporate Support Center, 1815 Satellite Blvd., 
Building 200, Duluth, GA 30097. The petition proposes to amend the food 
additive regulations in 21 CFR Part 573 Food Additives Permitted in 
Feed and Drinking Water of Animals to provide for the safe use of 
erythromycin thiocyanate as an antimicrobial processing aid in fuel-
ethanol fermentations with respect to its consequent presence in by-
product distiller grains used as an animal feed or feed ingredient.
    The potential environmental impact of this action is being 
reviewed. To encourage public participation consistent with regulations 
issued under the National Environmental Policy Act (40 CFR 1501.4(b)), 
the agency is placing the environmental assessment submitted with the 
petition that is the subject of this notice on public display at the 
Division of Dockets Management (see ADDRESSES) for public review and 
comment.
    Interested persons may submit to the Division of Dockets Management 
(see ADDRESSES) electronic or written comments regarding this document. 
Submit a single copy of electronic comments or two paper copies of any 
mailed comments, except that individuals may submit one paper copy. 
Comments are to be identified with the docket number found in brackets 
in the heading of this document. Received comments may be seen in the 
Division of Dockets Management between 9 a.m. and 4 p.m., Monday 
through Friday. FDA will also place on public display any amendments 
to, or comments on, the petitioner's environmental assessment without 
further announcement in the Federal Register. If, based on its review, 
the agency finds that an environmental impact statement is not required 
and this petition results in a regulation, the notice of availability 
of the agency's finding of no significant impact and the evidence 
supporting that finding will be published with the regulation in the 
Federal Register in accordance with 21 CFR 25.51(b).

    Dated: April 14, 2010.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2010-9420 Filed 4-22-10; 8:45 am]
BILLING CODE 4160-01-S